Life Sciences Ontario Appoints Four Board Members
Life Sciences Ontario announced on March 25, 2026 the appointment of four leaders — Amelia Swanson, Dave Smardon, Leslie Madden and Melody Greaves — to its Board of Directors following its Annual General Meeting. The appointees, from Medtech Canada, Bioenterprise Canada, Moderna Canada and the Canadian Nuclear Isotope Council, bring policy, industry and government-relations experience; LSO also presented its 2025 Annual Report at the meeting.
Scoring Rationale
Official LSO announcement names four sector leaders and accompanies the 2025 Annual Report. Scored moderately for credibility and actionable governance implications, but limited novelty and industry-wide scope keep the impact mid-range.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalLife Sciences Ontario Welcomes New Board Members in 2026 Following Annual General Meetingmontrealgazette.com
